Prognostic value of pacing-induced mechanical alternans in patients with mild-to-moderate idiopathic dilated cardiomyopathy in sinus rhythm

Journal of the American College of Cardiology

Volumn 47, Issue 7, 2006, Pages 1382-1389

  Hirashiki, Akihiro ^a,b   Izawa, Hideo ^b   Somura, Fuji ^c   Obata, Koji ^a   Kato, Tomoko ^b   Nishizawa, Takao ^a   Yamada, Akira ^b   Asano, Hiroyuki ^b   Ohshima, Satoru ^b   Noda, Akiko ^d   Iino, Shigeo ^b   Nagata, Kohzo ^d   Okumura, Kenji ^b   Murohara, Toyoaki ^b   Yokota, Mitsuhiro ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Nagoya Ekisaikai Hospital   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MESSENGER RNA; RYANODINE RECEPTOR;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE EXPRESSION; HEART ATRIUM PACING; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE BIOPSY; HEART RATE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SARCOPLASMIC RETICULUM; SINUS RHYTHM;

ADULT; CALCIUM-TRANSPORTING ATPASES; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; ENDOCARDIUM; FEMALE; HEART CONDUCTION SYSTEM; HEART DISEASES; HEART RATE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; PROGNOSIS; PROSPECTIVE STUDIES; RNA, MESSENGER; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SURVIVAL ANALYSIS;

EID: 33645381029     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.10.069     Document Type: Article

References (36)

1. G.W. Dec, V. Fuster Idiopathic dilated cardiomyopathy N Engl J Med 331 1994 1564 1575
2. L.W. Stevenson, M.B. Fowler, J.S. Schreder Poor survival of patients with idiopathic dilated cardiomyopathy considered too well for transplantation Am J Med 83 1987 871 876
3. J.N. Cohn, D.G. Archibald, S. Ziesche Effect of vasodilator therapy on mortality in chronic congestive heart failure N Engl J Med 314 1986 1547 1552
4. A.M. Keogh, J. Freund, D.W. Baron, J.B. Hickie Timing of cardiac transplantation in idiopathic dilated cardiomyopathy Am J Cardiol 61 1988 418 422
5. B. Pinamonti, A.D. Lenarda, G. Sinagra The Heart Muscle Disease study group Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by Doppler echocardiography clinical echocardiographic and hemodynamic correlation and prognostic implications J Am Coll Cardiol 22 1993 808 815
6. S. Kim, H. Izawa, T. Sobue Prognostic value of mechanical efficiency in ambulatory patients with idiopathic dilated cardiomyopathy in sinus rhythm J Am Coll Cardiol 39 2002 1264 1268
7. D. Logeart, G. Thabut, P. Jourdain Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure J Am Coll Cardiol 43 2004 635 641
8. V. Cheng, R. Kazanagra, A. Garcia A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure J Am Coll Cardiol 37 2001 386 391
9. M. Vanderheyden, M. Goethal, S. Verstreken Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy J Am Coll Cardiol 44 2004 2349 2354
10. M.M. Redfield, R.J. Rodeheffer, S.J. Jacobsen Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction. A community-based study Circulation 109 2004 3176 3181
11. B. Surawicz, C. Fisch Cardiac alternans diverse mechanisms and clinical manifestations J Am Coll Cardiol 20 1992 483 499
12. M.J. Lab, W.A. Seed Pulsus alternans Cardiovasc Res 27 1993 1407 1412
13. D.E. Euler Cardiac alternans mechanism and pathophysiological significance Cardiovasc Res 42 1999 583 590
14. M. Kodama, K. Kato, S. Hirono Mechanical alternans in patients with chronic heart failure J Card Fail 7 2001 138 145
15. J.M. Ryan, J.F. Schieve, H.B. Hull Experiences with pulsus alternans. Ventricular alternation and the stage of heart failure Circulation 14 1956 1099 1103
16. D.L. Dries, D.V. Exner, B.J. Gersh Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction a retrospective analysis of the SOLVD trials J Am Coll Cardiol 32 1998 695 703
17. D.M. Clark, V.J. Plumb, A.E. Epstein Hemodynamic effects of irregular sequence of ventricular cycle lengths during atrial fibrillation J Am Coll Cardiol 30 1997 1039 1045
18. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathy Br Heart J 44 1980 672 673
19. I. Mirsky Assessment of diastolic function suggested methods and future considerations Circulation 69 1984 836 841
20. 2+-ATPase mRNA expression and biphasic force-frequency relations in patients with hypertrophic cardiomyopathy Circulation 104 2001 658 663
21. M. Arai, N.R. Alpert, D.H. Maclennan Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium Circ Res 72 1993 463 469
22. C.S. Beuve, P.D. Allen, G. Dambrin Cardiac calcium release channel (ryanodine receptor) in control and cardiomyopathic human hearts mRNA and protein contents are differentially regulated J Mol Cell Cardiol 29 1997 1237 1246
23. A.G. Schmidt, V.J. Kadambi, N. Ball Cardiac-specific overexpression of calsequestrin results in left ventricular hypertrophy, depressed force-frequency relation and pulsus alternans in vivo J Mol Cell Cardiol 32 2000 1735 1744
24. M.J. Lab, J.A. Lee Changes in intracellular calcium during mechanical alternans in isolated ferret ventricular muscle Circ Res 66 1990 585 595
25. 2+ handling is the primary cause of mechanical alternans study in ferret ventricular muscles Am J Physiol 261 1991 H1746 H1755
26. I.S. Anand, V.G. Florea, L. Fisher Surrogate end points in heart failure J Am Coll Cardiol 39 2002 1414 1421
27. R. Berger, M. Huelsman, K. Strecker B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
28. R.W. Troughton, C.M. Frampton, T.G. Yandle Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
29. T. Tsutamoto, A. Wada, K. Maeda Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
30. K. Maeda, T. Tsutamoto, A. Wada High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J Am Coll Cardiol 36 2000 1587 1593
31. T.J. Wang, J.C. Evans, E.J. Benjamin Natural history of asymptomatic left ventricular systolic dysfunction in the community Circulation 108 2003 977 982
32. G. Cintron, G. Johnson, G. Francis Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure Circulation 87 Suppl VI 1993 VI17 VI23
33. M. Wong, L. Stazewsky, R. Latini Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure J Am Coll Cardiol 43 2004 2022 2027
34. J.R. Wilson, J.S. Schwartz, M.S. Sutton Prognosis in severe heart failure relation to hemodynamic measurements and ventricular ectopic activity J Am Coll Cardiol 2 1983 403 410
35. T.L. Kelly, R. Cremo, C. Nielsen Prediction of outcome in late-stage cardiomyopathy Am Heart J 119 1990 1111 1121
36. T.J. Kolias, K.D. Aaronson, W.F. Armstrong Doppler-derived dP/dt and -dP/dt predict survival in congestive heart failure J Am Coll Cardiol 36 2000 1594 1599